Table 1.
Randomization | Baseline characteristics of study and control groups | Co-interventions | Patient blinding |
Follow-up
(month) |
Lost to
follow-up/Total |
Outcome measurement | Score based on modified van Tulder list | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Objective | Calibrated investigators | Blinded investigators | |||||||||
MTA | CH | ||||||||||
Percinoto et al. [9] | Ok | NM | No | NM | 3,6,12 | 10/55 | 10/55 | Yes | Yes | Yes | 9 |
Moretti et al. [24] | Ok | NM* | No | NM | 3,6,12,18,24 | 1/15 | 1/15 | Yes | Yes | Yes | 11 |
Sonmez et al. [25] | Ok | NM | No | NM | 6,12,18,24 | 0/15 | 10/23 | Yes | No | No | 9 |
Liu et al. [13] | Ok | NM | NM | NM | 56 | 3/20 | 3/20 | Yes | NM | NM | 9 |
Oliviera et al. [26] | Ok | NM | No | NM | 6,12,24 | 0/15 | 0/15 | Yes | Yes | Yes | 12 |
NM: Not Mentioned